Please login to the form below

Not currently logged in
Email:
Password:

Zogenix

This page shows the latest Zogenix news and features for those working in and with pharma, biotech and healthcare.

Purdue gets FDA nod for abuse-deterrent painkiller

Purdue gets FDA nod for abuse-deterrent painkiller

The new product will compete in the marketplace against products such as Zogenix' 12-hour Zohydro ER (hydrocodone), another long-acting opioid analgesic which was approved by the FDA last year ... Zogenix filed for approval of a line extension based on

Latest news

  • Dancing with the Deval Dancing with the Deval

    One critic (among many) was Massachusetts state governor Deval Patrick, who announced he was banning Zohydro from his state until its maker Zogenix developed an abuse-deterrent version.

  • FDA releases guidance on how to prevent abuse of opioid painkillers FDA releases guidance on how to prevent abuse of opioid painkillers

    The guidance comes one month after an FDA advisory committee voted against the approval of opioid-containing Zohydro from Zogenix due in part to its potential for abuse. ... Zogenix is currently working on an abuse-deterrent formulation of its drug.

  • Migraine drugs' headache Migraine drugs' headache

    Injectable therapies are invasive and difficult to administer, while other therapies that exist, such as Zogenix's Sumavel DosePro needleless, are considered painful and can result in bruising.

  • Dermatology developments

    Phase II. 130. Durect/Zogenix. Licenses long acting injectable risperidone to combine with Zogenix needle-free system.

  • Next generation

    China . Sumatriptan needle-free injection . Sumavel DosePro (Zogenix, Astellas Pharma). Migraine, cluster headache.

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Mind+Matter Mind+Matter

    Spark Therapeutics, Superdrug, Thornton &Ross, Vetoquinol, VMIC,  Zogenix.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....